|
|
Article: Monitoring Allergen Immunotherapy of Pollen-Allergic Patients: The Ratio of Allergen-Specific IgG4 to IgG1 Correlates With Clinical Outcome.
- Article from:
- Immunotherapy Weekly
- Article date:
- May 31, 1999
CopyrightCOPYRIGHT 1999 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Allergy Medicine
Gehlhar, K.; Schlaak, M.; Becker, W.M.; Bufe, A. "Monitoring Allergen Immunotherapy of Pollen-Allergic Patients: The Ratio of Allergen-Specific IgG4 to IgG1 Correlates With Clinical Outcome." Clinical and Experimental Allergy, April 1999;29(4):497-506.
(CW HENDERSON PUBLISHER www.newsfile.com) -- According to the authors' abstract of an article published in Clinical and Experimental Allergy, "BACKGROUND: Although allergen immunotherapy [was] established as a treatment of type I allergy back in 1911, until now the underlying mechanisms have not been fully understood, nor are there any parameters which would allow one to monitor an ongoing ...